Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.80 -0.06 (-0.68%)
As of: Oct 23, 2026 · 3:07 PM EDT

Aspire Biopharma Holdings, Inc. (ASBP) Consolidated Net Income (2024 - 2026)

Updated

Aspire Biopharma Holdings' Consolidated Net Income came in at -$1.27 million for Q2 2026, compared with -$1.98 million a year earlier.

Analysis

Aspire Biopharma Holdings, Inc. (ASBP) Consolidated Net Income (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Aspire Biopharma Holdings reported Consolidated Net Income of -$15.2 million; for FY2025, it came in at -$24.48 million.

  • Going back by year, Consolidated Net Income was -$1.31 million in FY2024 and -$358,108 in FY2023.
  • The Q2 2026 figure represents the highest quarterly Consolidated Net Income since Q4 2024.
  • Business Quant data shows ASBP's Consolidated Net Income at -$3.22 million (Q1 2026), -$8.08 million (Q4 2025) and -$2.63 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.27 Mn
Mar 31, 2026 -3.22 Mn
Dec 31, 2025 -8.08 Mn
Sep 30, 2025 -2.63 Mn
Jun 30, 2025 -1.98 Mn
Mar 31, 2025 -15.94 Mn
Dec 31, 2024 -667,722.00
Sep 30, 2024 -216,269.00
API Access

Aspire Biopharma Holdings, Inc. Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=ASBP&period=max&api_key=YOUR_API_KEY